Inserm, Center for Research in Epidemiology and Population Health (CESP), U1018, Epidemiology of diabetes, obesity and chronic renal disease, 94807 Villejuif, France; University Paris-Sud, UMRS 1018, 94807 Villejuif, France.
Nutrition Department, hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France; Institute of Cardiology Metabolism and Nutrition, ICAN, 75013 Paris, France.
Diabetes Metab. 2015 Feb;41(1):55-61. doi: 10.1016/j.diabet.2014.11.007. Epub 2014 Dec 24.
This analysis estimates the prevalence of type 2 diabetes mellitus (T2DM) in French adults participating in the ObEpi (obesity epidemiology) 2012 survey and also proposes a description of that population, according to comorbidities, treatments and sociodemographic factors related to the disease.
A self-administered questionnaire was posted to 20,000 households from the Kantar Health panel. In total, 25,714 adults aged≥18 years and representative of the French population completed the survey between January and March 2012.
The prevalence of T2DM was 5.5±0.3% (95% CI) in this representative sample of the adult French population. Average age of patients was 65.9 years; 55% were men. Mean body mass index was 29.9kg/m(2) (men: 29.4kg/m(2), women: 30.6 kg/m(2); P<0.01); the prevalence of obesity was 43.1% (men: 39.9%, women: 47.1%; P<0.01). Patient-reported treatments for comorbidities were frequent: high blood pressure, 59.1%; dyslipidaemia, 59.9%; myocardial infarction/angina pectoris, 9.7%; revascularization, 7.8%; heart failure, 7.4%; sleep apnoea, 8.3%; and osteoarthritis, 10.7%. With regards to known treatments, 81.4% of patients were taking oral antidiabetic drugs (OADs), and 15.3% were using insulin therapy. Also, 18.8% of diabetic respondents reported financial hardship.
T2DM remains a disease of major concern: compared with the non-diabetic population, all parameters surveyed showed unfavourable ratings, particularly for women.
本分析旨在估计参加 2012 年 ObEpi（肥胖流行病学）调查的法国成年人中 2 型糖尿病（T2DM）的患病率，并根据合并症、治疗方法和与疾病相关的社会人口学因素，对该人群进行描述。
Kantar Health 小组向 20,000 个家庭邮寄了一份自填式问卷。共有 25,714 名年龄≥18 岁的成年人于 2012 年 1 月至 3 月期间完成了调查，该人群具有法国人口代表性。
在该成年法国人群的代表性样本中，T2DM 的患病率为 5.5±0.3%（95%置信区间）。患者的平均年龄为 65.9 岁；55%为男性。平均体重指数为 29.9kg/m²（男性：29.4kg/m²，女性：30.6kg/m²；P<0.01）；肥胖的患病率为 43.1%（男性：39.9%，女性：47.1%；P<0.01）。患者报告的合并症治疗方法较为常见：高血压 59.1%；血脂异常 59.9%；心肌梗死/心绞痛 9.7%；血管重建 7.8%；心力衰竭 7.4%；睡眠呼吸暂停 8.3%；骨关节炎 10.7%。在已知的治疗方法中，81.4%的患者服用口服降糖药（OADs），15.3%的患者使用胰岛素治疗。此外，18.8%的糖尿病患者报告存在经济困难。
T2DM 仍然是一个严重的问题：与非糖尿病患者相比，所有调查参数均显示出不利的评分，特别是女性。
